211 related articles for article (PubMed ID: 38203404)
21. Transplant-associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation.
Gavriilaki E; Sakellari I; Batsis I; Mallouri D; Bousiou Z; Vardi A; Yannaki E; Constantinou V; Tsompanakou A; Vadikoliou C; Kaloyannidis P; Bamihas G; Anagnostopoulos A
Clin Transplant; 2018 Sep; 32(9):e13371. PubMed ID: 30080283
[TBL] [Abstract][Full Text] [Related]
22. Clinical characteristics of pediatric allogeneic hematopoietic stem cell transplantation-associated thrombotic microangiopathy (TA-TMA): a retrospective single-center analysis.
Luo L; Xiong H; Chen Z; Yang L; Sun M; Lu W; Tao F; Wang Z; Li J; Li Z; Tang S
Clin Transl Oncol; 2023 Aug; 25(8):2451-2461. PubMed ID: 36973479
[TBL] [Abstract][Full Text] [Related]
23. [Clinical analysis of sirolimus as an alternative GVHD prophylaxis for patients with kidney injury undergoing allo-HSCT].
Sun W; Ma R; He Y; Bai L; Chen YY; Chen Y; Zhang YY; Wang JZ; Chen H; Zhang XH; Xu LP; Wang Y; Huang XJ; Sun YQ
Zhonghua Nei Ke Za Zhi; 2023 Dec; 62(12):1444-1450. PubMed ID: 38044071
[No Abstract] [Full Text] [Related]
24. Intestinal thrombotic microangiopathy: a distinct entity in the spectrum of graft-versus-host disease.
Gavriilaki E; Sakellari I; Karafoulidou I; Pasteli N; Batsis I; Mallouri D; Lazaridou A; Iskas M; Vardi A; Papalexandri A; Tsompanakou A; Papaemmanouil S; Ilias A; Anagnostopoulos A
Int J Hematol; 2019 Nov; 110(5):529-532. PubMed ID: 31586304
[TBL] [Abstract][Full Text] [Related]
25. Early remodeling of the colonic mucosa after allogeneic hematopoietic stem cells transplantation: An open-label controlled pilot study on 19 patients.
Coron E; Esnaud E; Chevallier P; Bessard A; Perez Cuadrado-Robles E; David G; Bossard C; Brégéon J; Jarry A; Neunlist M; Quénéhervé L
United European Gastroenterol J; 2021 Oct; 9(8):955-963. PubMed ID: 34431618
[TBL] [Abstract][Full Text] [Related]
26. Post-Transplantation Natural Killer Cell Count: A Predictor of Acute Graft-Versus-Host Disease and Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation.
Kim SY; Lee H; Han MS; Shim H; Eom HS; Park B; Kong SY
Clin Lymphoma Myeloma Leuk; 2016 Sep; 16(9):527-535.e2. PubMed ID: 27375156
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults.
Jodele S; Davies SM; Lane A; Khoury J; Dandoy C; Goebel J; Myers K; Grimley M; Bleesing J; El-Bietar J; Wallace G; Chima RS; Paff Z; Laskin BL
Blood; 2014 Jul; 124(4):645-53. PubMed ID: 24876561
[TBL] [Abstract][Full Text] [Related]
28. Thrombotic microangiopathy with concomitant GI aGVHD after allogeneic hematopoietic stem cell transplantation: Risk factors and outcome.
Zhang XH; Liu X; Wang QM; He Y; Zhu XL; Zhang JM; Han W; Chen H; Chen YH; Wang FR; Wang JZ; Zhang YY; Mo XD; Chen Y; Wang Y; Fu HX; Chang YJ; Xu LP; Liu KY; Huang XJ
Eur J Haematol; 2018 Feb; 100(2):171-181. PubMed ID: 29114931
[TBL] [Abstract][Full Text] [Related]
29. Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research.
Schoettler ML; Carreras E; Cho B; Dandoy CE; Ho VT; Jodele S; Moissev I; Sanchez-Ortega I; Srivastava A; Atsuta Y; Carpenter P; Koreth J; Kroger N; Ljungman P; Page K; Popat U; Shaw BE; Sureda A; Soiffer R; Vasu S
Transplant Cell Ther; 2023 Mar; 29(3):151-163. PubMed ID: 36442770
[TBL] [Abstract][Full Text] [Related]
30. Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin.
Fujiwara H; Maeda Y; Sando Y; Nakamura M; Tani K; Ishikawa T; Nishimori H; Matsuoka K; Fujii N; Kondo E; Tanimoto M
Transfusion; 2016 Apr; 56(4):886-92. PubMed ID: 26711692
[TBL] [Abstract][Full Text] [Related]
31. A pilot trial of prophylactic defibrotide to prevent serious thrombotic microangiopathy in high-risk pediatric patients.
Higham CS; Shimano KA; Melton A; Kharbanda S; Chu J; Dara J; Winestone LE; Hermiston ML; Huang JN; Dvorak CC
Pediatr Blood Cancer; 2022 May; 69(5):e29641. PubMed ID: 35253361
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of Recombinant Human Soluble Thrombomodulin in Treating Disseminated Intravascular Coagulation Complicating Allogeneic Hematopoietic Stem Cell Transplantation.
Inoue Y; Matsunawa M; Sano F; Miura I
Acta Haematol; 2018; 140(2):121-127. PubMed ID: 30227394
[TBL] [Abstract][Full Text] [Related]
33. [Thrombotic complications after hematopoietic stem cell transplantation].
Nomura S
Rinsho Ketsueki; 2017; 58(5):516-522. PubMed ID: 28592769
[TBL] [Abstract][Full Text] [Related]
34. Circulating Soluble Urokinase Plasminogen Activator Receptor as a Predictive Indicator for COVID-19-Associated Acute Kidney Injury and Mortality: Clinical and Bioinformatics Analysis.
Abdellatif HAA; Sultan BO; Nassar HM; Gomaa MEE; Sakr MG; Riad E; Al-Harbi AI; Abdulhakim JA; Fawzy MS; Abd El-Fadeal NM
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108340
[TBL] [Abstract][Full Text] [Related]
35. Integrating CAR T-Cell Therapy and Transplantation: Comparisons of Safety and Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation After CAR T-Cell or Chemotherapy-Based Complete Remission in B-Cell Acute Lymphoblastic Leukemia.
Zhao YL; Liu DY; Sun RJ; Zhang JP; Zhou JR; Wei ZJ; Xiong M; Cao XY; Lu Y; Yang JF; Zhang X; Lu DP; Lu P
Front Immunol; 2021; 12():605766. PubMed ID: 34025637
[TBL] [Abstract][Full Text] [Related]
36. Renal thrombotic microangiopathy associated with chronic humoral graft versus host disease after hematopoietic stem cell transplantation.
Mii A; Shimizu A; Masuda Y; Fujino T; Kaneko T; Utsumi K; Arai T; Ishikawa A; Wakamatsu K; Tajika K; Iino Y; Katayama Y; Fukuda Y
Pathol Int; 2011 Jan; 61(1):34-41. PubMed ID: 21166941
[TBL] [Abstract][Full Text] [Related]
37. Circulating dsDNA, endothelial injury, and complement activation in thrombotic microangiopathy and GVHD.
Gloude NJ; Khandelwal P; Luebbering N; Lounder DT; Jodele S; Alder MN; Lane A; Wilkey A; Lake KE; Litts B; Davies SM
Blood; 2017 Sep; 130(10):1259-1266. PubMed ID: 28705839
[TBL] [Abstract][Full Text] [Related]
38. Alterations of hemostatic parameters in the early development of allogeneic hematopoietic stem cell transplantation-related complications.
Han Y; Zhu L; Sun A; Lu X; Hu L; Zhou L; Ren Y; Hu X; Wu X; Wang Z; Ruan C; Wu D
Ann Hematol; 2011 Oct; 90(10):1201-8. PubMed ID: 21674145
[TBL] [Abstract][Full Text] [Related]
39. Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.
Zając-Spychała O; Wachowiak J; Pieczonka A; Siewiera K; Frączkiewicz J; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Jachna-Sawicka K; Wysocki M; Klepacka J; Goździk J; Zaucha-Prażmo A; Kowalczyk JR; Styczyński J
Transpl Infect Dis; 2016 Oct; 18(5):690-698. PubMed ID: 27479544
[TBL] [Abstract][Full Text] [Related]
40. Plasma from patients undergoing allogeneic hematopoietic stem cell transplantation promotes NETOSIS
López-Andrade B; Cunill V; Andreu V; Bento L; Segura-Guerrero M; Moñino A; Iglesias J; Julià MR; Durán MA; Ballester MC; Muncunill J; Sampol A
Front Immunol; 2024; 15():1353106. PubMed ID: 38550584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
